Posttranscriptional regulation by TIA1 and TIAL1 controls the transcriptional program enforcing T cell quiescence
Immune protection against infections relies on long-term maintenance of a highly diversified naïve T cell repertoire. Transcription factors cooperate to enforce T cell metabolic quiescence and maintenance. However, less is known about the posttranscriptional networks that preserve naïve T cells. Here, we describe the RNA binding proteins T cell antigen 1 (TIA1) and TIA-like 1 (TIAL1) as key promoters of CD4 and CD8 T cell quiescence. T cells deficient in TIA1 and TIAL1 undergo premature T cell activation, exhaustion, and death in the absence of cognate antigens. Mechanistically, TIA1 and TIAL1 promote the messenger RNA translation of quiescence-associated transcription factors such as forkhead box P1, lymphoid enhancer factor 1, and T cell factor 1 to restrain homeostatic T cell proliferation and activation. In summary, our study highlights a previously unrecognized dependency on posttranscriptional gene regulation by TIA1 and TIAL1 for implementing the quiescent transcriptional programs for long survival of T cells.
Authors
- Trang-My M. Nguyen (ORCID: https://orcid.org/0000-0002-9365-7276)
- Inés C. Osma-García (ORCID: https://orcid.org/0000-0002-3724-8371)
- Maïlys Mouysset
- Dunja Capitan-Sobrino (ORCID: https://orcid.org/0009-0002-2161-1516)
- Manuel D. Díaz‐Muñoz (ORCID: https://orcid.org/0000-0002-9227-7474)
- Yann Aubert (ORCID: https://orcid.org/0000-0002-9769-6133)
- Orlane Maloudi
Institutions
- Centre National de la Recherche Scientifique (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Inserm (FR)
- Institut Toulousain des Maladies Infectieuses et Inflammatoires (FR)
- Université de Toulouse (FR)
Publication Details
- Journal
- Science Advances
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1126/sciadv.aeh4461
- Citations
- 3
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 4.97
Funders
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer